Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
2 results loaded, newest first. End of these results.
Ad hoc announcement pursuant to Art. 53 LRU.S. clinical hold remains in place; study continues in all other countriesCompany initiates expansion of clinical sites and enrollment in Europe, Asia and Latin AmericaTopline data from ENIGMA-TRS 1 expected in Q1 2027MILAN and MORRISTOWN, N.J., Sept. 25…
Newron announced its financial results and operational highlights for the first half of 2026, including that topline 12-week results for its evenamide ENIGMA-TRS 1 study are expected in Q1 2027. The company also signed a financing agreement for up to EUR 38 million.